Buspirone as a systemic immunosuppressant
US5484788A · kind A · utility
5Cited by
44References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 1993 |
| Grant date | Jan 16, 1996 |
| Priority date | — |
| Expiry date | Mar 26, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for suppressing an immune response in a mammal by systemically treating the mammal with an effective amount of buspirone that is capable of inhibiting classic contact hypersensitivity reactions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.